inlexzo 225 MG Intravesical System

RxCUI: 2723391
RxNorm name: inlexzo 225 MG Intravesical System
Display name: inlexzo 225 MG Intravesical System
Full name: inlexzo 225 MG Intravesical System
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
INLEXZO	GEMCITABINE INTRAVESICAL	Janssen Biotech, Inc	3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb	2025-09-11	Warnings, Adverse reactions	Exact identifier rxcui: 2723391

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb	inlexzo 225 MG Intravesical System [PSN] · gemcitabine 225 MG Drug Implant [Inlexzo] [SBD] · Inlexzo 225 MG Intravesical System [SY]	3	1	These highlights do not include all the information needed to use INLEXZO safely and effectively. See full prescribing information for INLEXZO. INLEXZO™ (gemcitabine intravesical system) Initial U.S. Approval: 2025	20250911